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Sequences (MIPS) databases were reconciled. Ty elements and dubious open 
reading frames (ORFs) were excluded. The data set (5,790 proteins) and search 
results can be viewed at the URL http://acer.gen.tcd.ie/~khwolfe/yeast. 
Repetitive regions within proteins were masked using the SEG filter in BLAST. 
Statistical analysis. Chi-square tests (data not shown) indicate that 
duplicated genes in yeast are distributed in a highly non-random manner 
with regard to both the order in which homologous genes occur on pairs of 
chromosomes and the transcriptional orientations of those genes. A 
simultaneous origin of duplicate regions, as opposed to 55 independent 
duplications, is supported by a chi-square test on block orientations and by the 
lack of triplicated regions. The Poisson expectation if blocks were duplicated 
sequentially is for approximately 40 duplicated blocks, and 7 blocks that are 
replicated more than once (mainly triplicated). There is only one possible 
candidate for a triplicated region: the genes YDR474Q YDR492W<md GNP1 on 
chromosome IVand YOR019W, YOL002C and SCM2 on chromosome XV meet 
our criteria for a duplicated chromosomal region; this is not shown in Fig. 2 
because this area of chromosome IV overlaps with blocks 18 and 9, which have a 
higher density of homologues than the proposed chromosome IV/XV block. 
The three-gene match between chromosomes IV and XV is probably spurious, 
but even if this is counted as a triplication the departure from Poisson 
expectations is significant (P =  0.001).
Phylogenetic analysis. Protein sequences were aligned using default settings 
in ClustalW with manual editing to remove regions whose alignment was not 
clear. Branch lengths were estimated with correction for multiple hits25. The 
mean age of duplication was estimated as (Bl(A -f- B) +  C/(A +  Q)/2, where A , 
.B and C correspond to the lengths of branches A, B and C shown in Fig. 3. 
Confidence intervals were estimated by bootstrap analyses for genes where 
there were >10 inferred substitutions on branch A. One gene pair, ORC1/SÏR3, 
was omitted because one of the yeast genes appeared more similar to its human 
homologue than to its duplicate.
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Dendritic cells form a system of highly efficient antigen-present­
ing cells. After capturing antigen in the periphery, they migrate to 
lymphoid organs where they present the antigen to T cells1,2. Their 
seemingly unique ability to interact with and sensitize naive T 
cells gives dendritic cells a central role in the initiation of immune 
responses and allows them to be used in therapeutic strategies 
against cancer, viral infection and other diseases. How they 
interact preferentially with naive rather than activated T lympho­
cytes is still poorly understood. Chemokines direct the transport 
of white blood cells in immune surveillance3,4. Here we report the 
identification and characterization of a C-C chemokine (DC-CK1) 
that is specifically expressed by human dendritic cells at high 
levels. Tissue distribution analysis demonstrates that dendritic 
cells present in germinal centres and T-cell areas of secondary 
lymphoid organs express this chemokine. We show that DC-CK1, 
in contrast to RANTES, MIP-la and interleukin-8, preferentially 
attracts naive T cells (CD45RA+), The specific expression of DC- 
CK1 by dendritic cells at the site of initiation of an immune 
response, combined with its chemotactic activity for naive T cells, 
suggests that DC-CK1 has an important rule in the induction of 
immune responses.
Dendritic cells are key regulators in immune responses, capable of 
priming naive T cells. Their potent anti gen-presen ting capacity can 
be explained in part by their unique life cycle and their high 
expression of major histocompatibility complex (MHC) class I 
and II molecules as well as co-stimulatory molecules1. Detailed 
molecular analysis of dendritic cell function has been hampered, 
however, by the low numbers of dendritic cells present in blood 
mononuclear cells. The mechanism by which dendritic cells interact 
with or activate resting naive T cells to initiate an immune response 
is not fully understood. One possibility is that secreted cytokines or 
chemokines preferentially attract or activate naive rather than 
activated T cells. We generated sufficient numbers of dendritic 
cells in vitro5,6 to prepare a panel of dendritic-cell cDNA libraries, 
which allowed us to analyse dendritic cells at the molecular level.
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While searching at the genetic level for molecules expressed by 
dendritic cells, we identified a cDNA clone encoding a C-C 
chemokine that is abundantly expressed. The deduced sequence 
predicts a protein of 89 amino acids, of which the amino-terminal 
20 amino acids contain all the characteristics of a signal peptide 
(Fig. la). The mature protein comprises 69 amino acids and is 63%, 
38% and 33% identical to the chemokines MlP-la, RANTES and 
MCP-2, respectively (Fig. lb}. The idea that this chemokine is 
expressed abundantly by dendritic cells is supported by the finding 
that of 350 dendritic cell cDNAs analysed, six encode this C-C 
chemokine. We termed it DC-CK1.
An RNA species of 1.1 kb was readily detected by northern blot 
analysis in both total and poly(A)+ RNA isolated from dendritic 
cells (Fig. 2a). No DC-CK1 expression could be detected in T cell-, B 
cell- or three different monocyte cell lines. Moreover, freshly 
isolated resting or phytohaemagglutin (PHA)/interleukin (IL)-2
activated peripheral blood mononuclear cells (PBMCs), the resting 
or PHA/IL-2 activated non-adherent PBMC fraction (T, B and NK 
cells), and the adherent PBMC fraction (monocytes) activated with 
lipopolysaccharide (LPS) all failed to express this chemokine. Two 
endothelial cell lines, representatives of a non-leukocyte cell type 
known to be capable of expressing a variety of chemokines3,4, did 
not express the chemokine either (data not shown). Because 
dendritic cells abundantly expressing DC-CK1 were derived from 
purified monocytes cultured in the presence of GM-CSF and IL-4 
(refs 5-7), we tested the ability of different stimuli to induce its 
expression in monocytes. Fetal calf serum (FCS), interferon (IFN)-'y 
and LPS were all unable to induce DC-CK1 mRNA (Fig, 2b), To 
demonstrate further the specific induction of this chemoldne by 
GM-CSF plus IL-4 in monocytes, we cultured purified T cells in the 
presence of GM-CSF plus IL-4, with or without PHA/IL-2. No DC- 
CK1 mRNA could be detected in T cells under either of these
b
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Figure 1 a, Nucleotide and amino-acid sequence of DC-CKL Characteristic 
cysteines and the experimentally determined signal peptide are in italics. The 
non-consensus poly(A) site is underlined, b, Amino-acid comparison of mature 
DC-CK1 with the C-C chemokines MIP-la, MCP-2 and RANTES. The character­
istic cysteines are shown in bold. Identical amino acids (dashes) and gaps 
(asterisks) introduced for optimal alignment are indicated.
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Figure 2 DC-CK1 mRNA is specifically expressed by dendritic cells, a, Northern 
blot analysis of DC-CK.1 expression (filled arrow) in T (iurkat), B (EBV-B) and 
monocyte *THP-1, U937, MonoMac-6) cell lines, freshly isolated resting or 
activated (act) PBMC subsets and GM-SCF plus IL-4-generated dendritic cells 
before (DC and D-A+ for polyA+ RNA) and after activation with TNF-a plus IM a 
(DC-actand DC-act-A+ for po(yA+ RNA) as indicated above each lane, b, Northern 
analysis of DC-CK1 expression in monocyte-derived dendritic cells and freshly 
isolated monocytes (mono) stimulated as indicated and Tcells cultured in GM-
CSF plus IL-4 with or without activation with PHA/IL-2. c, Time course of DC-CK1 
mRNA expression in freshly isolated monocytes cultured in the presence of IL-4, 
GM-CSF or the combination for the time (days) indicated in brackets. Northern 
blots were hybridized to a DC-CKl-specific and a control 28S ribosomal (open 
arrow) probe. Analogous results were obtained when cDNA libraries prepared 
from most of the same cell types were examined on Southern blots after digestion 
to release their inserts (not shown).
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Figure 3 Detection of DC-CK1 in germinal centres and T-cell areas of a tonsil by in 
situ hybridization. Tonsil sections were stained with a sense (a) or antisense (b-d) 
DIG-labelled DC-CK1 RNA probe. Magnifications are x  40 (a, b) and x 200 for c 
(germinal centre) and d (T-celi area). The filled arrow indicates staining in the
germinal centres (GC) and the open arrow in a T-cell area. No staining was 
observed in the mantle zone (MZ). An incubation time of 2-3 h with NBT/BCIPwas 
sufficient to detect DC-CK1 mRNA, which is consistent with the abundance of 
DC-CK1 in the cDNA libraries.
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Figure 4 DC-CK1 is a potent chemoattractant for the 
CD45RA* T-cell subset, a, Migration of purified Tcells and 
the CD4\ CD81, CD45RA+ and CD45ROt T-cell subsets in 
response to DC-CK1 and RANTES is indicated as the 
number of migrated cells versus the amount of chemokine. 
Experiments using filters of 5-jjuti and 8-|im pore-size yielded 
similar results. Results shown are representative from 
experiments using 5-^m pore-size filters. Cells on the filter 
are counted from 5 fields under high power. Each point 
represents mean (±s.e.m.) number of migrating cells 
minus the number of cells in the medium control from 3 
experiments performed in duplicate, b, c, Migration of 
CD45RA+ and CD45RO+ T cells in response to DC-CK1, 
RANTES, MIP-1a and IL-8, and their sensitivity to 
100 ng m l"' pertussis toxin. The concentration of chemokine 
yielding the optimal response (10 ng ml" ’ forall chemokines) 
is shown. Results are representative from experiments using 
8-ixm pore-size filters. Each point represents mean (±s.e.m.) 
number of migrating cells minus the number of cells in the 
medium control from 3 experiments performed in duplicate.
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conditions (Fig. 2b). Splenocytes activated with IL-4 and anti-CD 40 
monoclonal antibodies also do not express DC-CKl (data not 
shown). Taken together, these data demonstrate that DC-CK1 is 
primarily expressed in dendritic cells but not in any of the other 
leukocytes tested.
To investigate the time required for the expression of DC-CK1 
and the dependence on GM-CSF and IL-4, a time-course experi­
ment was performed using either GM-CSF, IL-4 or a combination of 
both. No DC-CK1 mRNA could be detected in freshly isolated 
monocytes, 01* monocytes cultured for 24 h in any cytokine combi­
nation (Fig. 2c). However, after 3.5 days of culture, DC-CKl mRNA 
is abundantly present in cells cultured with either GM-CSF plus IL-4 
or IL-4 alone, but not with GM-CSF alone. After 6 days, DC-CK1 
mRNA is still present in abundance in GM-CSF plus IL-4 and IL-4 
cultured cells, whereas only a small amount can be discerned with 
GM-CSF alone. This latter finding might be explained by the 
survival of contaminating dendritic cells residing in the monocyte 
fraction. Collectively, these data indicate that high-level expression 
of DC-CK1 is dependent on the presence of IL-4. The finding that 
prolonged incubation in the presence of IL-4 (3.5 days) is required 
for the induction of DC-CKl mRNA is consistent with IL-4 being a 
key cytokine in directing the differentiation of monocytes towards 
the dendritic cell lineage, whereas GM-CSF is merely thought to act 
as a survival factor3,6.
To determine the number of dendritic cells in our preparations 
that express DC-CK1 mRNA, we did in situ hybridization (ISH) on 
cy to spins of dendritic cell cultures. The results demonstrated that 
most cells (65-90%) expressed DC-CKl mRNA, excluding the 
possibility of a contaminating cell population being responsible 
for its production (data not shown). To investigate the expression of 
DC-CKl in situ, ISH was performed on secondary lymphoid tissues, 
which are known to contain dendritic cells. DC-CKl-expressing cells 
were readily observed in T-cell areas (identified by CD34 staining of 
high endothelial venules8) and germinal centres of a tonsil (Fig. 3), 
consistent with the distribution and morphology of dendritic 
cells1,9. A similar expression pattern of DC-CKl mRNA was 
observed in lymph nodes. Staining of serial sections for DC-CKl 
by ISH and with monoclonal antibodies directed against CD68 and 
DRC-1/CD21 demonstrated that the DC-CKl-producing cells in 
die germinal centres were distinct from tingible body macrophages 
and follicular dendritic cells, respectively (data not shown). As 
determined with anti-CD3, -CD 19 and -CD 14 monoclonal anti­
bodies, the DC-CKl-positive cells are also distinct from T cells, B 
cells and monocytes (data not shown). The DC-CKl-expressing 
dendritic cells in germinal centres are likely to represent the recently 
identified T-cell stimulatory germinal-centre dendritic cells9.
Because dendritic cells are so important for the activation of 
unprimed T cells, we investigated the ability of DC-CKl to function 
as a chemoattractant for different T-cell subsets. Freshly isolated T 
cells respond optimally to lOngml"’1 DC-CKl (Fig. 4c), which is 
similar to the amount required for the potent T-cell chemoattrac­
tant RANTES. CD4+ and CD8+ T cells respond equally to DC-CKl. 
In contrast, separation of T lymphocytes into resting (CD45RA+) or 
activated (CD45RO+) subpopulations demonstrated that the main 
T-cell population attracted by DC-CKl consists of naive resting T 
cells. Checkerboard analysis demonstrated that the effect of DC- 
CKl 011 resting T cells is chemotactic rather than chemokinetic in 
nature (data not shown). The T-cell chemoattractants RANTES, 
MIP-la and IL-8 do not show this specificity for naive CD45RA'*" T 
cells10' 12 (Fig. 4b). DC-CKl may therefore be used by dendritic cells 
to preferentially attract naive T cells which, after recognition of 
peptide/MHC complexes presented by dendritic cells results in the 
induction of a primary immune response.
Chemokines induce chemotaxis when they interact with specific 
receptors that signal through hetero trim eric G proteins. As a 
consequence, chemotaxis is sensitive to pertussis toxin, a potent 
inhibitor of Goi{ proteins13. Pretreatment of cells with pertussis toxin
completely abrogated the chemotactic response of CD45RA+ T cells 
to DC-CKl (Fig. 4c). These data provide further evidence that DC- 
CKl acts primarily on the CD45RA+ T-cell subset, and indicate that 
the response to DC-CKl is a G protein-coupled receptor-mediated 
event.
The specific expression of a chemokine, DC-CKl, preferentially 
attracting naive T cells may be one of the mechanisms used by 
dendritic cells to interact preferentially with unprimed T cells, and is 
likely to be an important first step in the initiation of an immune 
response. Monoclonal antibodies directed against DC-CKl will be 
useful in analysing the lineage relationship between subsets of 
dendritic cells, as well as in defining stages of their activation and 
maturation14. Further, such antibodies will be an important tool for 
detecting dendritic cells in different pathological conditions, 
including cancer and HIV infection. Notably, HIV-1 infection has 
recently been shown to be suppressed by chemokines and to be 
dependent on chemokine receptors as a cell entry cofactor15,16. 
Further characterization of DC-CKl and its receptor will make 
clear its function as an immunoregulator and its importance in the 
biology of dendritic cells, including their role and that of DC-CKl in 
the pathogenesis of HIV. □
Methods
Cell culture. Dendritic cells were generated by culturing elutriated monocytes17 
(>90% CD14+) in Iscove’s medium with 5% FCS, SOOUml" 1 GM-CSF 
(Schering-Plough, The Netherlands) and 500 U m l-1 IL-4 (Schering-Plough) 
as described7. Dendritic were collected directly or after activation with LPS 
(2 jxgm l"l), TNF-a (IS n g m l"1) plus 75 LAF u m l“ 1 IL-la (Hoffman 
LaRoche, Nutley, NJ) or 40% monocyte supernatant for 4 h or 16 h. A mixture 
of the 4-h and 16-h portions was used for northern analysis and cDNA library 
construction. The phenotype and effects of subsequent stimulation were 
confirmed by FACS analysis5' 7. For northern analysis, total PBMC and the 
non-adherent fraction of PBMC were activated with 1 |xg ml " 1 PHA and 
20U m l-1 IL-2 (Cetus, Emmeryville) (PBMC-act; Non-Adh act) for 3 days. 
The adherent PBMC fraction was activated with 2fJLgml~‘ LPS for 2 days. 
Elutriated monocytes (>85% CD14+) were activated with 2jxgml“ 1 LPS. 
75Uml" 1 IFN-7 (Boehringer Ingelheim, Alkmaar, The Netherlands) or 5% 
FCS for 4 days and elutriated T cells (>95% CD3+) with GM-CSF 
(800Um l“ ') and IL-4 (SOOUml“ 1) with or without lfjigml" 1 PHA and 
20 U ml ” 1IL-2 for 3 days. T-cells subsets used for chemotaxis were obtained by 
negative selection with the appropriate cocktails of monoclonal antibodies 
against CD14 (Leu-M3), CD19 (Leu-12), CD20 (Leu-16), CD56 (Leu-19), 
CD45RA (Leu-18), CD45RO (Leu-45RO) (all Becton Dickinson, Mountain 
View, USA), CD67 (IOM-67, Immunotech, Westbrook), glycophorin 
(10F7MN, ATCC Rockville), CD4 (OKM-1) and CD8 (BL12) from ficoli 
banded mononuclear cells using sheep anti-mouse M-450 Dynabeads 
(Dynal, Oslo, Norway). Purity was >94% as determined by FACS analysis. 
cDNA library construction and northern blot analysis. Total RNA was 
isolated from the dendritic cell cultures described above using the guanidine 
thiocyanate/cesium chloride procedure, After isolation of poly(A)+ RNA 
(Oligotex, Qiagen), cDNA was synthesized and cloned into pSportl using 
the superscript plasmid system (Gibco BRL). Nucleotide sequence analysis of 
360 randomly picked clones was performed using the ABI system. For northern 
analysis, RNA isolated using the RNAzol B method (Biotecx Lab., Houston, 
TX) was used. As a DC-CKl-specific probe, we used a random primed labelled 
380-bp BSTX-I/No/1 fragment comprising the 3' non-coding region. Spotblots 
containing MIP-lo¿ cDNA were included in each hybridization to ensure 
specificity. To control for the amount and quality of the RNA samples, blots 
were also hybridized with a 28S ribosomal probe18.
Recombinant chemokines and chemotaxis. The N terminus of DC-CKl was 
defined by N-terminal sequencing of purified recombinant DC-CKl produced 
in COS-7 cells using the pFLAG system (International Biotechnologies, New 
Haven, CT). To produce recombinant DC-CKl used in the chemotaxis 
experiments, Escherichia coli strain X156F was transformed with the pOMP 
plasmid containing the mature DC-CKl coding region. After lysis, the 
periplasmic fraction was purified on Q-sepharose and S-sepharose columns 
(Pharmacia) using a linear NaCl gradient (0-0.1 M). The DC-CKl-enriched
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fractions were loaded on a reverse-phase column and eluted using a linear 
gradient of 2-80% acetonitrile. DC-CK1 protein concentration was estimated 
by densitometric scanning of a coomassie blue-stained gel containing lysozyme 
as a standard. RANTES, M IP-la and IL-8 were obtained from R&D Systems. T- 
cell migration was measured using 48-well chemotaxis chambers (Neuroprobe) 
as described19. In brief, chemokines in RPMI-1640 were added to the lower 
chamber and were separated from 105 cells in RPMI-1640 with 10% FCS by 
either a 8-|xm or a 5 fxm PVP-free polycarbonate membrane (Poretics, 
Livermore). After incubation for 1 h, the membrane was removed and the 
upper side washed with PBS, scraped to remove residual cells and washed again. 
After methanol fixation and staining, the number of fully migrated cells was 
counted microscopically in 5 high-power fields ( X 400) per well. Pertussis 
toxin (lOOngml-1) (Calbiochem) was used for 2h. Each experiment was 
performed in duplicate, and experiments with DC-CK1, RANTES, MIP-la and 
IL-8 were performed in parallel in the same assay to make a direct comparison 
of their activities possible.
In situ  hybridization. Cryosections (8 |j,m) of tonsils and lymph nodes were 
fixed in 4% paraformaldehyde and pretreated with 2 (jugml" 6 pepsin in 0.2 M 
HC1 for lOmin and 0.1 M triethanol amine/0.25 acetic acid anhydride for 
10 min. Sections were hybridized overnight with either a sense or an antisense 
DIG-labelled DC-CKl RNA probe consisting of the 3' non-coding region 
generated by in vitro transcription (Boehringer Mannheim). Before incubation 
with anti-DIG-alkaline phosphatase monoclonal antibody the sections were 
treated with 40 U m l" 1 RNAse I (Promega) to ensure specificity. After incuba­
tion for 2-3 h with nitroblue tetrazolium/5*-bromo-4-chloro-3-indolyl phos­
phate (Boehringer Mannheim) the sections were stained with methylene green 
and embedded in Kaiser’s. Immunostaining was performed as described20.
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Glial-cell-line-derived iteurotrophic factor (GDNF) and neur­
turin (NTN) are two structurally related, potent survival factors 
for sympathetic, sensory and central nervous system neurons1-6. 
GDNF mediates its actions through a multicomponent receptor 
system composed of a ligand-binding glycosyl-phosphatidylino- 
sitol (GPI)-linked protein (designated GDNFR-a) and the trans­
membrane protein tyrosine kinase Ret7-12. In contrast, the 
mechanism by which the NTN signal is transmitted is not well 
understood. Here we describe the identification and tissue dis­
tribution of a GPI-linked protein (designated NTNR-<x) that is 
structurally related to GDNFR-a. We further demonstrate that 
NTNR-a binds NTN (jCd'-10pM) but not GDNF with high 
affinity; that GDNFR-a binds to GDNF but not NTN with high 
affinity; and that cellular responses to NTN require the presence 
of NTNR-a. Finally, we show that NTN, in the presence of NTNR-
a, induces tyrosine-phosphorylation of Ret, and that NTN, 
NTNR-a and Ret form a physical complex on the cell surface. 
These findings identify Ret and NTNR-a as signalling and ligand- 
binding components, respectively, of a receptor for NTN and 
define a novel family of receptors for neurotrophic and differ­
entiation factors composed of a shared transmembrane protein 
tyrosine kinase and a ligand-specific GPI-linked protein.
In searching for a neurturin receptor, we examined sequences 
deposited in public databases for similarity to the GDNF receptor a 
component (GDNFR-a)9'10. Eight partial human cDNAs (Genbank 
accession numbers R02249, H12981, W73681, W73633, H05619, 
R02135, T03342 and HSC1KA111) were identified and found to 
encode parts of a single protein of 464 amino acids which we 
designated neurturin receptor a  (NTNR-a). The human proteins 
hNTNR-a and hGDNFR-a display an overall 48% similarity, and 
the positions of their cysteine residues are conserved (Fig. 1). Both 
hNTNR-a and hGDNFR-a seem to be extracellular proteins that 
are attached to the outer cell membrane by means of a glycosyl- 
phosphatidyl inositol (GPI) modification. hNTNR-a has an amino- 
terminal signal peptide for secretion, three glycosylation sites, and a 
stretch of 17 carboxy-terminal hydrophobic amino acids preceded 
by a group of three small amino acids (Gly, Ser, Asn) defining a 
cleavage/binding site for GPI linkage (Fig. 1). Subsequently, a rat 
NTNR-a (rNTNR-a) was isolated and shown to be 94% identical to 
its human homologue (Fig. I).
To examine whether NTNR-a could be a receptor for a neuro­
trophic factor such as NTN, the tissue distribution of NTNR-a 
mRNA was examined by in situ hybridization and compared with
NATURE I VOL 387112 JUNE 1997 717
